The original SARS-CoV-1 pandemic was also characterized by an extremely low prevalence of chronic lung disease comorbidities,40,41 an effect that could also have been driven by ICS-mediated suppression of ACE2 in these subjects. This evidence concerns the gene ACE2 and chronic lung disease.